Advertisement
U.S. Markets open in 1 hr 2 mins

Sage Therapeutics, Inc. (SAGE)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Visitors trend2W10W9M
7.65-0.14 (-1.80%)
At close: 04:00PM EDT
7.28 -0.37 (-4.84%)
After hours: 06:24PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close7.79
Open7.80
Bid0.00 x 0
Ask0.00 x 0
Day's Range7.45 - 7.83
52 Week Range5.84 - 28.26
Volume521,301
Avg. Volume706,542
Market Cap467.036M
Beta (5Y Monthly)0.91
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Zacks

    Sage Therapeutics, Inc. (SAGE) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

    Sage Therapeutics (SAGE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • GuruFocus.com

    State Street Corp's Strategic Acquisition of Sage Therapeutics Shares

    On September 30, 2024, State Street Corp made a significant addition to its investment portfolio by acquiring 451,377 shares of Sage Therapeutics Inc (NASDAQ:SAGE) at a price of $7.22 per share. This transaction increased State Street Corp's total holdings in Sage Therapeutics to 2,926,239 shares, marking a notable expansion in their investment in the biotechnology sector. State Street Corp, headquartered at One Lincoln Street, Boston, MA, is a prominent financial services provider known for its robust investment strategies.